'Hero' mom's quick thinking catches corporation releasing toxic pollution: 'Never underestimate how much power you have'
Her story was highlighted in the Environmental Defense Fund's Vital Signs newsletter, which explained that upon cracking her window to take the video, Rowoldt became nauseated and dizzy and developed a headache. She thought about just returning home to her children but couldn't ignore the pollution.
Rowoldt ultimately showed her video to a local official, which led to an Ohio EPA investigation into Freepoint Eco-Systems. EDF explained that the company — which is now under scrutiny for releasing a number of known carcinogens, including styrene, dioxins, and furans, into the air — is an "advanced recycling facility," which essentially means it burns plastic.
"Environmental experts say it's not recycling at all and produces dangerous air pollution," the organization said.
In addition to cancer, the chemicals that Freepoint Eco-Systems released can lead to many other health issues. For instance, dioxins are highly toxic and can cause reproductive and developmental problems as well as damage to the immune system, and they can interfere with hormones, according to the U.S. Environmental Protection Agency.
Rowoldt isn't the only mom taking a stand for her community when it comes to pollution. For instance, a Michigan mom is cleaning up trash and encouraging others to keep their neighborhoods clean by dressing like a clown. Lois Gibbs, another mom, became an activist for public health amid toxic pollution in her Niagara Falls, New York, neighborhood in the late 1970s and 1980s. Parents across the country, including Rowoldt, are coming together via the Moms Clean Air Force, a 1.5-million-strong coalition fighting against pollution, toxic chemicals, and global warming.
You can find even more good news stories, including articles on global warming solutions, news, and actions you can take, in the Vital Signs newsletter.
Rowoldt encouraged others to take action if they see pollution.
"Never underestimate how much power you have," she told EDF.
Do you worry about air pollution in and around your home?
Yes — always
Yes — often
Yes — sometimes
No — never
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
RaySearch and Radiology Oncology Systems form partnership
RaySearch Laboratories and Radiology Oncology Systems have formed a partnership, aiming to expand access to cancer treatment technology. The companies look to capitalise on opportunities involving new and existing technologies, emphasising the integration of refurbished linear accelerators with 'advanced' software tools. The aim is to provide comprehensive solutions that not only extend the lifecycle of linear accelerators but also promote sustainability in radiation therapy. By doing so, the two companies are working towards improving care and strengthening their market positions. This initiative challenges the routine scrapping of fully functional linear accelerators after ten years, advocating for their refurbishment and use in centres with limited technology. The collaboration, which aims to provide comprehensive solutions that broaden access to radiation therapy, has already produced several agreements. Radiology Oncology Systems president John V Vano said: 'Too many cancer patients around the world face a critical gap between their need for care and the advanced technology available. Our collaboration with RaySearch allows us to help our customers expand their access to critical, life-changing care.' Under this collaboration, RaySearch is expected to see increased adoption of its RayStation treatment planning system and RayCare oncology information system (OIS). RaySearch founder and CEO Johan Löf said: 'Access to care is critical for us to fulfil our vision of a world where cancer is conquered. This partnership, with its combination of refurbished linacs and advanced software solutions, can really make a difference.' Two centres in Argentina have placed orders for Varian Trilogy linear accelerators while a US centre has chosen TrueBeam and RayStation. A Mexican centre has selected Elekta Versa HD and RayStation. Earlier this year, Odense University Hospital (OUH) in Denmark ordered the RayStation system. "RaySearch and Radiology Oncology Systems form partnership" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Epoch Times
24-06-2025
- Epoch Times
Bread Versus Coke: How Different Sugars Impact Your Body
We often think of sugar as the white crystals we stir into coffee or sprinkle on desserts. However, sugar comes in many forms—and some of the most harmful types are hidden in everyday foods you wouldn't suspect. Dr. Jason Fung, a physician and kidney specialist, explained on Epoch TV's 'Vital Signs' that sugar's real danger isn't how sweet something tastes—but how it behaves in the body. He said that fructose, a sugar found in fruit and processed foods, may quietly contribute to fatty liver, obesity, and Type 2 diabetes, even if it doesn't cause a noticeable spike in blood sugar. The Different Types of Sugar Each type of sugar affects our body differently. Knowing the different types of sugars helps us make smart diet choices, manage blood sugar levels, and achieve optimal health benefits. Glucose Glucose is found in starches and carbohydrates like bread, rice, and potatoes. Your body uses glucose as a source of energy. Glucose raises blood sugar faster than other sugars, stimulates insulin release, and is delivered to your cells for use. However, excess glucose is turned into glycogen and stored in muscles or the liver until the body needs it.
Business Wire
24-06-2025
- Business Wire
Tivic Health Announces 2025 Annual Meeting of Stockholders
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time | 4:00 PM Eastern Time. The Company has adopted a virtual format for its Annual Meeting to provide a consistent and convenient experience for all stockholders regardless of their location. In lieu of a live Q&A session, stockholders can submit questions for management's consideration through the virtual Annual Meeting platform both before and during the Annual Meeting. Only stockholders of record of shares of Tivic Health's common stock at the close of business on May 14, 2025 are entitled to notice of and to vote at, the Annual Meeting. To attend online and participate in the Annual Meeting, stockholders of record will need to use the control number included on the proxy card they received in the mail to log into the Annual Meeting. Beneficial owners who do not have a control number may gain access to the Annual Meeting by logging into their brokerage firm's website and selecting the stockholder communication mailbox to link through to the Annual Meeting. Instructions should also be provided on the voting instruction card provided by their broker, bank, or other nominee. The company's Proxy Statement, proxy card and Annual Report on Form 10-K for the year ended December 31, 2024, are available on the Internet at: SEC Filings - Tivic Health. About Tivic Health Systems, Inc. Tivic Health is a diversified immunotherapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. Tivic Health's bioelectronic program is focused on developing personalized non-invasive therapeutic devices for vagus nerve stimulation to improve clinical outcomes in inflammatory, neurologic and cardiac disease. The program also includes Tivic Health's first FDA approved product, ClearUP®, which has been proven to provide temporary relief of sinus pain, pressure and congestion and is available through top-tier online retail and distribution partners. The company's newly formed biopharmaceutical program is focused on commercial advancement of the toll-like receptor 5 drugs Entolimod™ and Entolasta™, including lead product candidate Entolimod for acute radiation syndrome. The company is also driving expansion into additional indications for Entolimod and Entolasta. For more information about Tivic Health, visit: Forward-Looking Statements This press release may contain 'forward-looking statements' that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as 'anticipate,' 'believe,' 'contemplate,' 'could,' 'estimate,' 'expect,' 'intend,' 'seek,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'target,' 'aim,' 'should,' 'will,' 'would,' or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems Inc.'s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of risks and uncertainties relevant to the company, and other important factors, see Tivic Health's filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 21, 2025, under the heading 'Risk Factors', as well as the company's subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and the company undertakes no duty to update such information except as required by applicable law.
